| Literature DB >> 25939297 |
Carlos Rojas-Fernandez1, Zain Hudani2, Vera Bittner3.
Abstract
Statins are widely used in secondary and primary prevention of atherosclerotic cardiovascular disease. They reduce cardiovascular events and mortality, and have an excellent safety record. Recent case reports suggest a possible association between statins and adverse effects on cognition. This article reviews recent literature related to statins and cognition and provides recommendations to clinicians. Cognitive considerations should not play a role in decision making for most patients for whom statins are indicated. Future trials of statin, or any novel antilipemic agent should include systematic assessment of cognition.Entities:
Keywords: Adverse drug effects; Cognition; Drug safety; Iatrogenesis; Memory; Statins
Mesh:
Substances:
Year: 2015 PMID: 25939297 DOI: 10.1016/j.ccl.2015.02.008
Source DB: PubMed Journal: Cardiol Clin ISSN: 0733-8651 Impact factor: 2.213